Metheor Therapeutics Corp — Form D/A
Metheor Therapeutics Corp of SHORELINE, WA, a company, filed a Form D amendment with the SEC on 2015-10-30. The offering totals $200K, of which $90K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-10-30
- Form: D/A
- Accession: 0001528276-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $90K
- Remaining: $110K
- Minimum investment: $5K
- Investors: 7
- Date of first sale: 2014-11-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-228045
Issuer
- Name: Metheor Therapeutics Corp
- CIK: 0001528276
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2010
- Address: 17736 15TH AVE. NW, SHORELINE, WA, 98177
- Phone: (206) 546-3466
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Bruce LA Carter | Director | Seattle, WA |
| Robert Z Day | Director | Shoreline, WA |
| R. Gary Schweikhardt | Director | Shoreline, WA |
| Andrew Z Sledziewski | Director | Shoreline, WA |
| Theo Z DeVos | Executive Officer | Shoreline, WA |
| Andrew Z Sledziewski | Executive Officer | Shoreline, WA |
| Gary Z Schweikhardt | Director | Shoreline, WA |
Other filings by this issuer (2)
More